Zacks Investment ResearchWed, 13 May 2026 14:40:19 GMTWhy Viatris (VTRS) is a Top Value Stock for the Long-TermVTRS-0.63%
Seeking AlphaTue, 12 May 2026 20:00:56 GMTViatris Inc. (VTRS) Presents at Bank of America Global Healthcare Conference 2026 TranscriptVTRS-0.63%
Zacks Investment ResearchTue, 12 May 2026 14:46:07 GMTWhy Viatris (VTRS) is a Top Growth Stock for the Long-TermVTRS-0.63%
Seeking AlphaTue, 12 May 2026 08:54:00 GMTViatris: From Cost Story To Pipeline-Driven Re-Rating (Rating Upgrade)VTRS-0.63%
Seeking AlphaMon, 11 May 2026 16:55:46 GMTViatris: The Cigar Butt Got Smoked, But I'm Holding The RatingVTRS-0.63%
Zacks Investment ResearchThu, 07 May 2026 18:41:16 GMTViatris Q1 EPS Beats Estimates, Revenues up 8% Driven by Greater ChinaVTRS-0.63%
Seeking AlphaThu, 07 May 2026 18:21:18 GMTViatris Inc. (VTRS) Q1 2026 Earnings Call TranscriptVTRS-0.63%
Zacks Investment ResearchThu, 07 May 2026 14:31:33 GMTHere's What Key Metrics Tell Us About Viatris (VTRS) Q1 EarningsVTRS-0.63%
Zacks Investment ResearchThu, 07 May 2026 13:55:51 GMTViatris (VTRS) Q1 Earnings and Revenues Surpass EstimatesVTRS-0.63%
Zacks Investment ResearchWed, 06 May 2026 14:15:37 GMTExploring Analyst Estimates for Viatris (VTRS) Q1 Earnings, Beyond Revenue and EPSVTRS-0.63%
Zacks Investment ResearchTue, 05 May 2026 18:20:17 GMTViatris Gears Up to Report Q1 Earnings: What's in the Cards?VTRS-0.63%
Zacks Investment ResearchThu, 30 Apr 2026 15:01:20 GMTViatris (VTRS) Earnings Expected to Grow: Should You Buy?VTRS-0.63%
Seeking AlphaWed, 25 Mar 2026 23:15:57 GMTViatris Inc. (VTRS) Discusses Long-Term Growth Outlook and Portfolio Strategy Across Generics, Established Brands and Innovative Medicines TranscriptVTRS-0.63%
Zacks Investment ResearchWed, 04 Mar 2026 15:41:21 GMTViatris (VTRS) is a Top-Ranked Value Stock: Should You Buy?VTRS-0.63%
Seeking AlphaThu, 26 Feb 2026 22:08:13 GMTViatris Inc. (VTRS) Q4 2025 Earnings Call TranscriptVTRS-0.63%
Zacks Investment ResearchThu, 26 Feb 2026 17:46:31 GMTViatris Q4 EPS Tops, Brands Drive Revenue Growth, Stock UpVTRS-0.63%
Zacks Investment ResearchThu, 26 Feb 2026 16:01:57 GMTViatris (VTRS) Surpasses Q4 Earnings and Revenue EstimatesVTRS-0.63%
Zacks Investment ResearchThu, 26 Feb 2026 16:01:08 GMTViatris (VTRS) Q4 Earnings: Taking a Look at Key Metrics Versus EstimatesVTRS-0.63%
Zacks Investment ResearchMon, 23 Feb 2026 15:16:50 GMTUnveiling Viatris (VTRS) Q4 Outlook: Wall Street Estimates for Key MetricsVTRS-0.63%
Zacks Investment ResearchMon, 23 Feb 2026 15:11:13 GMTWhat's in Store for These 5 Medical Companies This Earnings Season?VTRS-0.63%
